z-logo
open-access-imgOpen Access
The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma
Author(s) -
David Y.A. Dadey,
Vaishali Kapoor,
Arpine Khudanyan,
Fumihiko Urano,
Albert H. Kim,
Dinesh Thotala,
Dennis E. Hallahan
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6712
Subject(s) - radioresistance , atf6 , unfolded protein response , downregulation and upregulation , gene knockdown , endoplasmic reticulum , cancer research , medicine , glioblastoma , regulator , viability assay , radiation therapy , cell , microbiology and biotechnology , biology , apoptosis , gene , biochemistry , genetics
Therapeutic resistance is a major barrier to improvement of outcomes for patients with glioblastoma. The endoplasmic reticulum stress response (ERSR) has been identified as a contributor to chemoresistance in glioblastoma; however the contributions of the ERSR to radioresistance have not been characterized. In this study we found that radiation can induce ER stress and downstream signaling associated with the ERSR. Induction of ER stress appears to be linked to changes in ROS balance secondary to irradiation. Furthermore, we observed global induction of genes downstream of the ERSR in irradiated glioblastoma. Knockdown of ATF6, a regulator of the ERSR, was sufficient to enhance radiation induced cell death. Also, we found that activation of ATF6 contributes to the radiation-induced upregulation of glucose regulated protein 78 (GRP78) and NOTCH1. Our results reveal ATF6 as a potential therapeutic target to enhance the efficacy of radiation therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom